Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Rodrigues

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 2, 2018
Human Pluripotent Stem Cell-Derived Kidney Model for Nephrotoxicity StudiesPiyush Bajaj, A David Rodrigues, Claire M Steppan, et al.
Bioanalysis|September 6, 2022
Development and implementation of urinary transporter biomarkers to facilitate assessment of drug-drug interactionLina Luo, Manoli Vourvahis, Lauren Horlbogen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pumpA David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
The AAPS Journal|January 6, 2021
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine ExposureSarah Badaoui, Ashley M Hopkins, A David Rodrigues, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2019
Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1Emi Kimoto, Manoli Vourvahis, Renato J Scialis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 22, 2018
Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule TherapeuticsAarti Sawant-Basak, A David Rodrigues, Matthew Lech, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitorPing Lu, Michael L Schrag, Donald E Slaughter, et al.
Archives of Biochemistry and Biophysics|September 9, 2006
Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductaseBo Wen, Jed N Lampe, Arthur G Roberts, et al.
Biochemical Pharmacology|February 1, 2020
Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7)Sumathy Mathialagan, Yi-An Bi, Chester Costales, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 4, 2018
PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3Takashi Yoshikado, Kota Toshimoto, Kazuya Maeda, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 2, 2018
Human Pluripotent Stem Cell-Derived Kidney Model for Nephrotoxicity StudiesPiyush Bajaj, A David Rodrigues, Claire M Steppan, et al.
Bioanalysis|September 6, 2022
Development and implementation of urinary transporter biomarkers to facilitate assessment of drug-drug interactionLina Luo, Manoli Vourvahis, Lauren Horlbogen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pumpA David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
The AAPS Journal|January 6, 2021
Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine ExposureSarah Badaoui, Ashley M Hopkins, A David Rodrigues, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2019
Mechanistic Evaluation of the Complex Drug-Drug Interactions of Maraviroc: Contribution of Cytochrome P450 3A, P-Glycoprotein and Organic Anion Transporting Polypeptide 1B1Emi Kimoto, Manoli Vourvahis, Renato J Scialis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 22, 2018
Physiologically Relevant, Humanized Intestinal Systems to Study Metabolism and Transport of Small Molecule TherapeuticsAarti Sawant-Basak, A David Rodrigues, Matthew Lech, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitorPing Lu, Michael L Schrag, Donald E Slaughter, et al.
Archives of Biochemistry and Biophysics|September 9, 2006
Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductaseBo Wen, Jed N Lampe, Arthur G Roberts, et al.
Biochemical Pharmacology|February 1, 2020
Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7)Sumathy Mathialagan, Yi-An Bi, Chester Costales, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 4, 2018
PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3Takashi Yoshikado, Kota Toshimoto, Kazuya Maeda, et al.
Pageof 14